Monte Rosa Therapeutics (GLUE)
(Delayed Data from NSDQ)
$5.69 USD
-0.32 (-5.32%)
Updated Sep 6, 2024 04:00 PM ET
After-Market: $5.71 +0.02 (0.35%) 7:58 PM ET
3-Hold of 5 3
F Value B Growth A Momentum C VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
11/14/2024
Time: -- |
9/2024 | $-0.45 | 3.50% |
Earnings Summary
For their last quarter, Monte Rosa Therapeutics (GLUE) reported earnings of -$0.43 per share, beating the Zacks Consensus Estimate of $-0.50 per share. This reflects a positive earnings surprise of 14.00%. Look out for GLUE's next earnings release expected on November 14, 2024. For the next earning release, we expect the company to report earnings of -$0.45 per share, reflecting a year-over-year increase of 35.71%.
Earnings History
Price & Consensus
Zacks News for GLUE
Recent Price Trend in Monte Rosa Therapeutics (GLUE) is Your Friend, Here's Why
GLUE: What are Zacks experts saying now?
Zacks Private Portfolio Services